Professor David Linch
HCA Healthcare UK at University College Hospital, 5th Floor, Macmillan Cancer Centre, Huntley Street, London WC1E 6AG
Determining defective genes that give rise to acute leukaemia so as to better define prognosis and to develop novel therapeutic approaches. Ascertainment of the features of lymphoma that determine response to therapy. Development and evaluation of transplantation and gene therapy strategies for leukaemia and lymphoma.
Prof David Linch is head of the department of haematology and chairman of the Cancer Research UK Cancer Centre at UCL. He is a founding member of the Academy of Medical Sciences. Prof Linch has been chairman of the National Cancer Research Institute lymphoma clinical studies group and is president of the Lymphoma Association.